Mensch und Maschine Software SE header image

Mensch und Maschine Software SE

MUM

Equity

ISIN DE0006580806 / Valor 664473

Xetra (2024-11-22)
EUR 52.80-0.56%

Mensch und Maschine Software SE
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Mensch und Maschine Software SE is a leading provider of CAD/CAM software solutions for the architecture, engineering, and construction industries.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (14.08.2024):

Record Earnings Growth

Mensch und Maschine Software SE reported strong earnings for the final quarter of 2023, achieving new record figures. The company saw an EPS growth of +17% per annum over the two years 2022/23, aligning perfectly with their original guidance of +14-20% from 2021.

Sales and Gross Profit

Preliminary figures indicate that Mensch und Maschine Software SE's sales for 2023 were approximately EUR 322 million, slightly above the previous year's EUR 320.48 million. The gross profit increased disproportionately to approximately EUR 168.5 million, a 4.6% rise from the previous year.

Operating Profit and EBIT Margin

The operating profit (EBIT) for Mensch und Maschine Software SE rose to approximately EUR 46.8 million, a 10% increase from the previous year. The EBIT margin also improved, reaching 14.5% compared to the previous year's 13.3%.

Net Profit and Cash Flows

Net profit after minority shares grew by 11% to approximately EUR 28.8 million, translating to 172 cents per share. Operating cash flows surged by more than a quarter to a new record amount of approximately EUR 50 million, or 300 cents per share.

Dividend Proposal and Outlook

Mensch und Maschine Software SE plans to propose a dividend of 160 cents per share, a 14% increase from the previous year. The company also provided a positive outlook for 2024, expecting an EPS increase of +10-20% and a dividend increase of +20-30 cents per share.

Summarized from source with an LLMView Source

Key figures

5.18%1Y
-18.6%3Y
27.2%5Y

Performance

27.3%1Y
32.9%3Y
36.4%5Y

Volatility

Market cap

949 M

Market cap (USD)

Daily traded volume (Shares)

1,911

Daily traded volume (Shares)

1 day high/low

53.4 / 52.3

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Paylocity Holding Corp
Paylocity Holding Corp Paylocity Holding Corp Valor: 23606709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.75%USD 205.28
Medpace Holdings Inc
Medpace Holdings Inc Medpace Holdings Inc Valor: 33038552
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.19%USD 337.75
Amdocs Ltd
Amdocs Ltd Amdocs Ltd Valor: 922906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.55%USD 85.67
Exelixis Inc
Exelixis Inc Exelixis Inc Valor: 1069927
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.24%USD 35.61
MACOM Technology Solutions Holdings Inc
MACOM Technology Solutions Holdings Inc MACOM Technology Solutions Holdings Inc Valor: 13504866
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.41%USD 134.50
Topicus.com Inc
Topicus.com Inc Topicus.com Inc Valor: 57260697
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.01%CAD 118.00
CommVault Systems Inc
CommVault Systems Inc CommVault Systems Inc Valor: 2517585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.29%USD 174.60
Ascendis Pharma
Ascendis Pharma Ascendis Pharma Valor: 26912602
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.85%USD 129.81
Lattice Semiconductor Corp
Lattice Semiconductor Corp Lattice Semiconductor Corp Valor: 946589
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.73%USD 54.21
Nebius Group N.V.
Nebius Group N.V. Nebius Group N.V. Valor: 12955842
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.77%USD 23.49